Estrella Immunopharma, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2023 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Estrella Immunopharma, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2023 to Q1 2024.
  • Estrella Immunopharma, Inc. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2024 was $0.000.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $0 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $0 Dec 31, 2023 10-Q 2024-02-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.